Acute Promyelocytic Leukemia — Trials

Acute Promyelocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

89 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 8
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05497310	Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL	unknown	Phase 1 / Phase 2	15	Hospital Universitario Dr. Jose E. GonzalezOTHER	1	Oct 26, 2022	clinicaltrials
NCT03624270	Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia	unknown	Phase 2	60	The University of Hong KongOTHER	1	Oct 4, 2022	clinicaltrials